Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study
10.1182/bloodadvances.2022006960
Saved in:
Main Authors: | Jang, Jun Ho, Wong, Lily, Ko, Bor-Sheng, Yoon, Sung-Soo, Li, Katie, Baltcheva, Irina, Nidamarthy, Prasanna Kumar, Chawla, Raghav, Junge, Guido, Yap, Eng Soo |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Language: | English |
Published: |
ELSEVIER
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/237840 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies
by: Kulasekararaj, AG, et al.
Published: (2023) -
Corticosteroids therapy in paroxysmal nocturnal hemoglobinuria
by: Surapol Issaragrisil, et al.
Published: (2018) -
Cytometric analysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
by: A. Bunyaratvej, et al.
Published: (2018) -
Mechanism of paroxysmal nocturnal hemoglobinuria clonal dominance: Possible roles of different apoptosis and CD8+ lymphocytes in the selection of paroxysmal nocturnal hemoglobinuria clones
by: Rajita Kunyaboon, et al.
Published: (2018) -
Transient paroxysmal nocturnal hemoglobinuria during the course of aplastic anemia
by: M. Kruatrachue, et al.
Published: (2018)